🇺🇸 FDA
Patent

US 7256281

Recombinant P. falciparum merozoite protein-142 vaccine

granted A61KA61K39/00A61K39/015

Quick answer

US patent 7256281 (Recombinant P. falciparum merozoite protein-142 vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K39/00, A61K39/015, A61P, A61P31/04